Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IGMS - Calithera Lung Cancer Trial And Other News: The Good Bad And Ugly Of Biopharma

IGMS - Calithera Lung Cancer Trial And Other News: The Good Bad And Ugly Of Biopharma

IGM Biosciences Inc.
  • Calithera initiates Phase 2 trial for lung cancer treatment.
  • Vertex receives FDA approval for cystic fibrosis treatment.
  • IGM Biosciences makes a deal with AbCellera for antibody discovery.

For further details see:

Calithera Lung Cancer Trial, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: IGM Biosciences Inc.
Stock Symbol: IGMS
Market: NASDAQ
Website: igmbio.com
Menu
IGMS IGMS Quote IGMS Short IGMS News IGMS Articles IGMS Message Board
Get IGMS Alerts

News, Short Squeeze, Breakout and More Instantly...